| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelin Proteins | 9 | 2008 | 76 | 1.040 |
Why?
|
| Neurons | 11 | 2018 | 1933 | 0.610 |
Why?
|
| Nerve Regeneration | 5 | 2007 | 86 | 0.600 |
Why?
|
| Axons | 6 | 2007 | 382 | 0.560 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2018 | 191 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2001 | 174 | 0.450 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 76 | 0.440 |
Why?
|
| Apolipoprotein E4 | 3 | 2018 | 43 | 0.440 |
Why?
|
| Receptors, Cell Surface | 5 | 2008 | 471 | 0.430 |
Why?
|
| Prosencephalon | 1 | 2011 | 40 | 0.370 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 82 | 0.350 |
Why?
|
| Synapses | 2 | 2011 | 448 | 0.340 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 172 | 0.340 |
Why?
|
| Recovery of Function | 4 | 2005 | 433 | 0.310 |
Why?
|
| Pyramidal Tracts | 2 | 2004 | 36 | 0.290 |
Why?
|
| Spinal Cord Injuries | 3 | 2005 | 311 | 0.280 |
Why?
|
| Apoptosis | 4 | 2001 | 1792 | 0.270 |
Why?
|
| Nogo Proteins | 7 | 2007 | 9 | 0.240 |
Why?
|
| Alzheimer Disease | 4 | 2018 | 763 | 0.230 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 29 | 0.220 |
Why?
|
| Staurosporine | 3 | 1999 | 21 | 0.220 |
Why?
|
| Cell Differentiation | 1 | 2011 | 1936 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2001 | 558 | 0.210 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2001 | 13 | 0.200 |
Why?
|
| Etoposide | 1 | 2001 | 119 | 0.190 |
Why?
|
| Central Nervous System | 1 | 2001 | 255 | 0.170 |
Why?
|
| Glucose | 1 | 2004 | 876 | 0.170 |
Why?
|
| Dopamine | 3 | 1999 | 275 | 0.160 |
Why?
|
| Mice | 19 | 2018 | 17647 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1999 | 56 | 0.160 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 47 | 0.150 |
Why?
|
| Argininosuccinate Lyase | 1 | 2018 | 60 | 0.150 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 57 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3075 | 0.150 |
Why?
|
| Animals | 21 | 2018 | 33923 | 0.150 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 114 | 0.140 |
Why?
|
| Pars Compacta | 1 | 2017 | 5 | 0.140 |
Why?
|
| Growth Cones | 2 | 2008 | 17 | 0.140 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 122 | 0.140 |
Why?
|
| Ventral Tegmental Area | 1 | 2017 | 50 | 0.140 |
Why?
|
| RNA Interference | 1 | 2018 | 497 | 0.140 |
Why?
|
| Cell Line | 9 | 2017 | 2787 | 0.140 |
Why?
|
| Mice, Knockout | 8 | 2017 | 3782 | 0.130 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 126 | 0.130 |
Why?
|
| DNA | 1 | 2001 | 1608 | 0.130 |
Why?
|
| Rats | 6 | 2011 | 3665 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 376 | 0.130 |
Why?
|
| Gene Dosage | 1 | 2017 | 441 | 0.130 |
Why?
|
| Transfection | 4 | 2011 | 1076 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2017 | 241 | 0.130 |
Why?
|
| Nogo Receptor 1 | 5 | 2008 | 9 | 0.130 |
Why?
|
| Genome | 1 | 2018 | 471 | 0.130 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2017 | 214 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2017 | 310 | 0.120 |
Why?
|
| GPI-Linked Proteins | 5 | 2008 | 94 | 0.120 |
Why?
|
| Endothelial Cells | 1 | 2018 | 529 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 5 | 2001 | 70 | 0.120 |
Why?
|
| bcl-X Protein | 4 | 2001 | 32 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2018 | 745 | 0.110 |
Why?
|
| Proteomics | 1 | 2017 | 477 | 0.110 |
Why?
|
| Myelin Sheath | 2 | 2004 | 133 | 0.110 |
Why?
|
| Neurogenesis | 2 | 2012 | 196 | 0.100 |
Why?
|
| Brain | 4 | 2012 | 2961 | 0.100 |
Why?
|
| Myocytes, Cardiac | 1 | 2017 | 618 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 942 | 0.100 |
Why?
|
| Seizures | 1 | 2017 | 875 | 0.100 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2012 | 35 | 0.100 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2012 | 81 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2002 | 110 | 0.100 |
Why?
|
| Microscopy, Electron | 2 | 2011 | 402 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2012 | 85 | 0.100 |
Why?
|
| Dendritic Spines | 2 | 2012 | 56 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2011 | 1024 | 0.100 |
Why?
|
| Purines | 1 | 2012 | 107 | 0.100 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 2443 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 80 | 0.090 |
Why?
|
| Motor Activity | 2 | 2004 | 508 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2011 | 269 | 0.090 |
Why?
|
| Gene Duplication | 1 | 2012 | 358 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 463 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2017 | 1043 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1634 | 0.090 |
Why?
|
| Parkinson Disease | 1 | 2017 | 670 | 0.090 |
Why?
|
| Caspases | 2 | 2001 | 160 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 669 | 0.080 |
Why?
|
| Hypertension | 1 | 2018 | 1275 | 0.080 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 39 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 2060 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 514 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 84 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1302 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2589 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 4308 | 0.070 |
Why?
|
| Cell Count | 2 | 2004 | 253 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 751 | 0.070 |
Why?
|
| Hippocampus | 2 | 2002 | 816 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 147 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2011 | 1116 | 0.070 |
Why?
|
| Homozygote | 2 | 2018 | 535 | 0.070 |
Why?
|
| Neuronal Plasticity | 2 | 2008 | 274 | 0.070 |
Why?
|
| Schizophrenia | 1 | 2008 | 297 | 0.060 |
Why?
|
| Plaque, Amyloid | 1 | 2006 | 62 | 0.060 |
Why?
|
| Mutation | 4 | 2017 | 5794 | 0.060 |
Why?
|
| Humans | 18 | 2018 | 122853 | 0.060 |
Why?
|
| Behavior, Animal | 2 | 2004 | 477 | 0.060 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2006 | 121 | 0.060 |
Why?
|
| 5,7-Dihydroxytryptamine | 1 | 2004 | 1 | 0.060 |
Why?
|
| Phospholipid Ethers | 1 | 2004 | 8 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2004 | 19 | 0.060 |
Why?
|
| Serotonin Agents | 1 | 2004 | 14 | 0.060 |
Why?
|
| Desipramine | 1 | 2004 | 27 | 0.060 |
Why?
|
| Species Specificity | 2 | 2018 | 552 | 0.060 |
Why?
|
| Cyclic AMP | 2 | 2002 | 247 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2004 | 218 | 0.060 |
Why?
|
| Evoked Potentials, Motor | 1 | 2004 | 34 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2004 | 260 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 449 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 2004 | 73 | 0.060 |
Why?
|
| Receptors, Peptide | 1 | 2004 | 48 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 104 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2006 | 206 | 0.060 |
Why?
|
| Time Factors | 3 | 2004 | 6202 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 1717 | 0.060 |
Why?
|
| Serotonin | 1 | 2004 | 222 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 2003 | 56 | 0.050 |
Why?
|
| Axotomy | 1 | 2003 | 11 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2007 | 4392 | 0.050 |
Why?
|
| Spatial Behavior | 1 | 2003 | 15 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1529 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 900 | 0.050 |
Why?
|
| Fetal Viability | 1 | 2003 | 29 | 0.050 |
Why?
|
| Schwann Cells | 1 | 2003 | 60 | 0.050 |
Why?
|
| Cycloheximide | 2 | 1999 | 43 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2004 | 305 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2004 | 239 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 16 | 0.050 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2001 | 22 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 98 | 0.050 |
Why?
|
| Genotype | 2 | 2018 | 2536 | 0.050 |
Why?
|
| Calpain | 1 | 2001 | 41 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 582 | 0.050 |
Why?
|
| Female | 8 | 2018 | 65278 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 773 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2017 | 1617 | 0.050 |
Why?
|
| Male | 9 | 2018 | 59866 | 0.050 |
Why?
|
| Genetic Therapy | 1 | 2005 | 706 | 0.040 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 1999 | 3 | 0.040 |
Why?
|
| Phenotype | 3 | 2007 | 4220 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2001 | 278 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 1999 | 28 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2001 | 679 | 0.040 |
Why?
|
| Proteins | 1 | 2004 | 1045 | 0.040 |
Why?
|
| Cell Death | 1 | 1999 | 243 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 1999 | 1404 | 0.040 |
Why?
|
| Alleles | 2 | 2017 | 1599 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8120 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 37 | 0.040 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2018 | 78 | 0.040 |
Why?
|
| Protein Phosphatase 1 | 1 | 2017 | 50 | 0.040 |
Why?
|
| Kinetics | 1 | 1999 | 1316 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 240 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 159 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2017 | 196 | 0.030 |
Why?
|
| Stroke | 1 | 2004 | 957 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 328 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2017 | 326 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2017 | 363 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 439 | 0.030 |
Why?
|
| Proteome | 1 | 2017 | 233 | 0.030 |
Why?
|
| Cell Movement | 2 | 2012 | 838 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1007 | 0.030 |
Why?
|
| Cell Survival | 3 | 2002 | 817 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 397 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2017 | 639 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 1097 | 0.030 |
Why?
|
| Drosophila | 1 | 2018 | 766 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3083 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 804 | 0.030 |
Why?
|
| Rolipram | 2 | 2002 | 2 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 1317 | 0.030 |
Why?
|
| Bromodeoxyuridine | 2 | 2002 | 61 | 0.030 |
Why?
|
| Antigens, Differentiation | 2 | 2002 | 63 | 0.030 |
Why?
|
| Myocardium | 1 | 2017 | 983 | 0.030 |
Why?
|
| Lesch-Nyhan Syndrome | 1 | 2012 | 11 | 0.030 |
Why?
|
| Receptors, Purinergic P2Y1 | 1 | 2012 | 12 | 0.030 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2012 | 5 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2012 | 59 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2012 | 40 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2012 | 65 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 94 | 0.020 |
Why?
|
| Lentivirus | 1 | 2012 | 84 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2814 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 111 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 288 | 0.020 |
Why?
|
| Cell Division | 2 | 2002 | 793 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 351 | 0.020 |
Why?
|
| beta Catenin | 1 | 2012 | 209 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2321 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 320 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 19037 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 664 | 0.020 |
Why?
|
| Codon | 1 | 2008 | 97 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2008 | 131 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 670 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 273 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 155 | 0.020 |
Why?
|
| DNA Fragmentation | 2 | 1998 | 53 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2012 | 973 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2541 | 0.020 |
Why?
|
| Child | 2 | 2018 | 24168 | 0.020 |
Why?
|
| Decerebrate State | 1 | 2007 | 1 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 882 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 65 | 0.020 |
Why?
|
| Biotin | 1 | 2007 | 41 | 0.020 |
Why?
|
| Dextrans | 1 | 2007 | 45 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3888 | 0.020 |
Why?
|
| Artifacts | 1 | 2007 | 103 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1067 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2006 | 122 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 2833 | 0.020 |
Why?
|
| Locomotion | 1 | 2005 | 69 | 0.020 |
Why?
|
| Heterozygote | 1 | 2007 | 682 | 0.010 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2004 | 30 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 1689 | 0.010 |
Why?
|
| Sialyltransferases | 1 | 2002 | 6 | 0.010 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 9928 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2002 | 28 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2002 | 19 | 0.010 |
Why?
|
| Colforsin | 1 | 2002 | 49 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 410 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2007 | 4524 | 0.010 |
Why?
|
| Fluoxetine | 1 | 2002 | 43 | 0.010 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2002 | 11 | 0.010 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2002 | 22 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2002 | 52 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 13858 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2002 | 245 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 1217 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 390 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2002 | 286 | 0.010 |
Why?
|
| Aging | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Emetine | 1 | 1999 | 7 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1999 | 9 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 26 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1999 | 68 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 39 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1999 | 42 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 1999 | 123 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 18917 | 0.010 |
Why?
|
| Cytosol | 1 | 1999 | 160 | 0.010 |
Why?
|
| Oxidopamine | 1 | 1998 | 15 | 0.010 |
Why?
|
| Vitamin K | 1 | 1998 | 35 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 113 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1997 | 4 | 0.010 |
Why?
|
| Neomycin | 1 | 1997 | 37 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 1999 | 150 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1997 | 29 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1997 | 318 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 528 | 0.010 |
Why?
|
| Gene Expression | 1 | 1998 | 1592 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1997 | 520 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 12070 | 0.000 |
Why?
|